Cha Ki-Chul has been the Chief Executive Officer of InBody Co.,Ltd (formerly known as Biospace Co., Ltd.) since 1995. Dr. Cha served as an Assistant Manager of Daelim R&D Institute. Dr. Cha was a Researche...

InBodyLtd 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

No independent directors

No independent directors

Recent updates

Full year 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of ₩300 per share at 1.2% yield

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 18%

Upcoming dividend of ₩200 per share

No independent directors

InBody Releases BPBIO 220 and BPBIO 250

No independent directors

Inbody Co.,Ltd Releases New Bwa 2.0 Body Water Analyzer

Upcoming dividend of ₩140 per share

Price target increased to ₩34,000

Investor sentiment improved over the past week

InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Full year 2020 earnings released: EPS ₩1,335 (vs ₩1,532 in FY 2019)

Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

New 90-day high: ₩19,600

How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: ₩19,200

Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

New 90-day high: ₩18,500

InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Upcoming Dividend of ₩140 Per Share

Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

New 90-day high: ₩18,300

InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

New 90-day high: ₩17,450

New 90-day low: ₩15,300

New 90-day low - ₩15,350

CEO

테뉴어